Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988-2012: A single-institution, high-volume experience in China

Annals of Surgery

Volumn 263, Issue 1, 2016, Pages 88-95

  Liu, Kai ^a   Yang, Kun ^a   Zhang, Weihan ^a   Chen, Xiaolong ^a   Chen, Xinzu ^a   Zhang, Bo ^a   Chen, Zhixin ^a   Chen, Jiaping ^a   Zhao, Yongfan ^a   Zhou, Zongguang ^a   Chen, Longqi ^a   Hu, Jiankun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Esophagogastric junctional adenocarcinoma; Gastroesophageal reflux disease; Proportion; Time; Trends

Indexed keywords

ABDOMINAL BLEEDING; ABDOMINAL INFECTION; ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURGERY; CHEST INFECTION; CHINA; CHINESE; CHYLOTHORAX; CLINICAL FEATURE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRIC JUNCTIONAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SURGERY; HIGH VOLUME HOSPITAL; HUMAN; IVOR LEWIS OPERATION; LONGITUDINAL STUDY; LUNG COMPLICATION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PANCREAS FISTULA; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; STOMACH ADENOCARCINOMA; STOMACH PARESIS; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; THORACOABDOMINAL ESOPHAGECTOMY; THORACOTOMY; TOTAL STOMACH RESECTION; TRANSHIATAL PROXIMAL GASTRECTOMY; TRANSHIATAL TOTAL GASTRECTOMY; ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL JUNCTION; MIDDLE AGED; TIME FACTOR;

ADENOCARCINOMA; ADULT; CHINA; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITALS, HIGH-VOLUME; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84953836924     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001148     Document Type: Article

References (46)

1. Jemal A, Bray F, Melissa M, et al. Global cancer statistics 2011. CA Cancer J Clin. 2011;61:69-90.
2. Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63-73.
3. Katrina FT, Susan AS, Sherri LS. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008;123:1422-1428.
4. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
5. Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662-1665.
6. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol. 2002;14:107-113.
7. Ahn HS, Lee HJ, Yoo MW, et al. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011;98:255-260.
8. Park MW, Bae JM, Kim SW, et al. Annual change of clinicopathologic characteristics after radical gastrectomy due to gastric cancer. J Kor Surg Soc. 2009;77:88-95.
9. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57:1354-1359.
10. Ness-Jensen E, Lindam A, Lagergren J, et al. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61:1390-1397.
11. Nouraie M, Radmard AR, Zaer-Rezaii H, et al. Hygiene could affect GERD prevalence independently: a population-based study in Tehran. Am J Gastroenterol. 2007;102:1353-1360.
12. Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol. 2005;100:759-765.
13. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100:747-753.
14. Zhou Y, Zhang Z, Zhang Z, et al. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18-25.
15. Stein HJ, Feith M, Siewert JR. Cancer of the esophagogastric junction. Surg Oncol. 2000;9:35-41.
16. Siewert JR, Stein HJ. Classification of adenocarcinoma of the esophagogastric junction. Br J Surg. 1998;85:1457-1459.
17. Kenneth RD, Donald OC. Update guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190-200.
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101-112.
19. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Handbook. 7th ed. New York, NY: Springer-Verlag; 2010.
20. Johnson ML, Gordon HS, Petersen NJ, et al. Effect of definition of mortality on hospital profiles. Med Care. 2002;40:7-16.
21. Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol. 2008;34:36-41.
22. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644-645.
23. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
24. Park SM, Lim MK, Shin SA, et al. Impact of pre-diagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024.
25. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-esophageal reflux disease: a systematic review. Gut. 2005;54:710-717.
26. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19:357-367.
27. Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26-29.
28. Thrift AP, Kramer JR, Qureshi Z, et al. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013;108:915-922.
29. Chak A, Falk G, Grady WM. Assessment of familiarity, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol. 2009;104:1913-1921.
30. Merry AH, Schouten LJ, Goldbohm RA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503-1511.
31. Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol. 2006;21:1362-1365.
32. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus and esophageal cancer: scientific review. JAMA. 2002;287:1972-1981.
33. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
34. Wang K, Yang CQ, Duan LP, et al. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China. Tumori. 2012;98:568-574.
35. Siewert JR, Feith M, Werner M. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical (topographic classification in 1002 consecutive patients. Ann Surg. 2000;232:353-361.
36. De Manzoni G, Pedrazzani C, Pasini F, et al. Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg. 2002;73:1035-1040.
37. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139-146.
38. Hasegawa S, Yoshikawa T, Cho H, et al. Is adenocarcinoma of the esophagogastric junction difference between Japan and Western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009;33:95-103.
39. Bai JG, Lv Y, Dang CX. Adenocarcinoma of the esophagogastric junction in China according to Siewert's classification. Jpn J Clin Oncol. 2006;36:364-367.
40. Chung JW, Lee GH, Choi KS, et al. Unchanging trend of esophagogastric junctional adenocarcinoma in Korea: experience at a single institution based on Siewert's classification. Dis Esophagus. 2009;22:676-681.
41. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127-130.
42. Kitamura K, Yamaguchi T, Okamoto K, et al. Total gastrectomy for early gastric cancer. J Surg Oncol. 1995;60:83-88.
43. Yoo CH, Sohn BH, Han WK, et al. Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. World J Surg. 2005;29:1592-1599.
44. An JY, Youn HG, Choi MG, et al. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg. 2008;196:587-591.
45. Wu CW, Chang IS, Lo SS, et al. Complications following D3 gastrectomy: post hoc analysis of a randomised trial. World J Surg. 2006;30:12-16.
46. Bozzetti F, Gianotti L, Braga M, et al. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr. 2007;26:698-709.